Australia markets open in 19 minutes

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
26.68+1.03 (+4.02%)
At close: 04:00PM EDT
26.68 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate0.050.04-0.110.58
Low estimate-0.01-0.1-0.450.31
High estimate0.160.130.180.92
Year ago EPS-0.19-0.45-5.64-0.11
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate42.1M43.05M170.84M181.89M
Low estimate39.9M42M170.02M179.3M
High estimate45M43.66M171.5M187M
Year ago sales40.56M41.47M166.66M170.84M
Sales growth (year/est)3.80%3.80%2.50%6.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.27-0.37-0.26-0.19
Actual EPS-0.19-0.45-4.3-0.31
Difference0.08-0.08-4.04-0.12
Surprise %29.60%-21.60%-1,553.80%-63.20%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate0.050.04-0.110.58
7 days ago0.050.04-0.110.58
30 days ago0.06-0.01-0.150.41
60 days ago0.090.030-0.05
90 days ago-0.1-0.09-0.310.21
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A222
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesANIKIndustrySector(s)S&P 500
Current qtr.126.30%N/AN/AN/A
Next qtr.108.90%N/AN/AN/A
Current year98.00%N/AN/AN/A
Next year627.30%N/AN/AN/A
Next 5 years (per annum)10.00%N/AN/AN/A
Past 5 years (per annum)-43.92%N/AN/AN/A